Journal article
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
K Savage, J Firth, C Stough, J Sarris
Phytotherapy Research | WILEY | Published : 2018
DOI: 10.1002/ptr.5940
Abstract
Anxiety disorders are chronic and functionally disabling conditions with high psychological stress, characterised by cognitive symptoms of excessive worry and focus difficulties and physiological symptoms such as muscle tension and insomnia. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter within the central nervous system and is a key target of pharmacotherapies in the treatment of anxiety. Although current pharmaceutical treatments are often efficacious, they may cause undesirable side effects including cognitive decrements and withdrawal symptoms. Plant-based “phytomedicines” may provide novel treatment options, to act as an adjunctive or alternative to existing anxiolytic..
View full abstractGrants
Awarded by Chaminade University of Honolulu
Funding Acknowledgements
K. S. is supported by Australian Government Research Training Program (RTP) Scholarship. J. F. is supported by a Blackmores Institute Fellowship. J. S. is supported by an NHMRC fellowship (APP1125000).